The consulting firm Deloitte surveyed 153 fresh food manufacturers and retailers and 2000 consumers to understand why fresh food is lagging and to assess the challenges ahead.
Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.